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Angiotensin binding and the effects of angiotensin on adenylate cyclase activity were determined on 
purified membranes from the glomerulosa zone of bovine adrenal cortex. Angiotensin II inhibited 
adenylate cyclase activity in a dose-dependent manner with an &-value of 2 nM. The angiotensin effect 
required the presence of GTP. Angiotensin also inhibited ACTH-stimulated activity. Angiotensin binding 
was sensitive to the same effecters which influenced angiotensin-induced adenylate cyclase inhibition. In 
the presence of NaCl 100 mM and magnesium, angiotensin teracted with a single population of binding 
sites (Kd = 4 nM and maximal binding capacity of 440 fmol/mg protein). These results and published ata 
suggest that the ability to inhibit adenylate cyclase might be a general property of angiotensin receptors. 
Angiotensin II Adenylate cyclase Receptor 
1. INTRODUCTION 
It has been convincingly demonstrated that the 
angiotensin-induced glycogenolytic response of 
isolated hepatocytes is mediated by a rise in 
cytosolic calcium concentration [l]. Current ex- 
perimental evidence indicates that calcium also 
plays a predominant role in several other actions of 
angiotensin such as its vasopressor [2] or 
steroidogenic effect on the adrenal cortex [3]. On 
the other hand, it was shown that angiotensin in- 
hibits adenylate cyclase from rat liver [4,5], rat 
renal cortex [6], and rat anterior pituitary mem- 
branes (Gaillard et al., in preparation) in a GTP- 
dependent manner. Angiotensin receptors were 
found to be sensitive to GTP, as most receptors 
positively or negatively coupled to adenylate 
cyclase [7]. The above mentioned data might be in- 
terpreted as indicating the existence of two types of 
angiotensin receptors, receptors of one type being 
functionally coupled to the adenylate cyclase and 
receptors of the other type with the yet uniden- 
tified effector responsible for calcium mobiliza- 
tion. Alternatively, they might be interpreted by 
assuming that angiotensin receptors have the 
peculiar property of being functionally coupled to 
two distinct transduction mechanisms (adenylate 
cyclase inhibition and calcium mobilization). In- 
deed, it has been shown that receptors such as 
hepatic vasopressin and cYi-adrenergic receptors 
which can mediate calcium mobilization in 
hepatocytes are not negatively coupled to 
adenylate cyclase. To test the two above 
hypotheses we studied the effect of angiotensin on 
bovine and rat adrenal cortex adenylate cyclase, 
angiotensin-binding to adrenal cortex receptors 
was also determined. The choice of this material 
was justified by the fact that there is phar- 
macological evidence that angiotensin receptors 
from adrenal cortex are different from other 
angiotensin receptors at least with respect to their 
recognition patterns [8]. 
2. MATERIALS AND METHODS 
2.1. Membrane preparation 
Purified bovine adrenal cortex membranes were 
prepared as in [9] with minor modifications. 
Adrenals were collected at the slaughterhouse, 
cleaned from surrounding fat and kept in cold, 
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calcium and magnesium-fret phosphate-buffered 
saline (PBS). The outer portion of the adrenal car- 
tex including the capsula and adhering cells from 
the ~omerulosa zone were separated by dissection. 
Ceils were scraped off from the capsuia, rinsed in 
cold PBS and homogenized in NaHCOs 20 mM by 
10 strokes in a loose Dounce homogenizer. A crude 
membrane fraction was prepared by two successive 
centrifugatio~s at 1500 and 20000 x g, Membranes 
were purified using a disco~t~uous sucrose gra- 
dient (31.5%, 38.5%, w/w) centrifuged for 
120 min at 25000 rev.&in in a Beckman SW 28 
rotor. Membranes collected at the top of the 
31.5% sucrose layer were sedimented in 20 mM 
NaHC03 by centrifugation at 40000 x g for 
40 min and suspended in 1 mM NaHCO3. All ex- 
periments were performed using freshly prepared 
membr~es. Crude membranes from rat fwistar) 
adrenal cortex were prepared as follows: The cor- 
tical portions of 30 adrenals were homogenized as 
indicated for bovine adrenal membr~es” Ceil 
debris was eliminated by centrifugation at 600 x g 
for 15 min and a crude membrane fraction col- 
lected by ~~ntrifugation at 30~ x g for 30 min. 
Membranes were suspended in 1 mM NaHCG3. 
2.2. Adenyhte cyclase assuy 
The incubation medium (100 yi final vol.) was 
composed of triethanoiamine-HCi, 50 mM (pH 
7.4); [cr-“P]ATP, 50 pM, 1 &i/assay; ATP, 
100 pM; isobutyimethyixanthine, 1 mM; creatine 
phosphate, 10 mM; creatine kinase, 0.2 mg/mi; 
adenosine d~samin~e, 10 units/ml; myokinase, 
36 units/ml; GTP 10 FM; 13H]cAMP, 0.01 
&X/assay; and various amounts of NaCi, MgCiz 
and hormonal agents tested. After thermal equiii- 
bration at 25°C the reaction was initiated by ad- 
ding membranes (30-50,ug protein), allowed to 
proceed for 10 min, and stopped by adding 900~1 
of a solution containing sodium dodecyi sulphate, 
1% (w/w); ATP, 1 mM; and CAMP, 1 mM. 
Labeled CAMP was separated using the procedure 
in [lo] as modified in [l I]. All determinations were 
performed in triplicate or q~adrupli~te. Proteins 
were determined as in 1121 using bovine serum 
albumin as a standard. 
2.3. rHfAHgiutensin_bind~~g assay 
[‘HfTyr4-labeled Asp’, VaiS an8iotensin 
~[3Hlangiote~sin) was prepared as in [13]. It was 
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purified by high pressure liquid chromatography 
to a specific radioactivity of 14 Ci/mmoi. The in- 
cubation medium (final vol. 250 pl) was composed 
of trieth~ol~ine-HCi, 50 mM (pH 7.4); bovine 
serum albumin, 1 mg/ml; bacitracine, 0.5 mglml; 
and various amounts of NaCi, MgClz and 
t3H~~giotensin. When the effects of GTP were 
tested, the incubation medium contained a 
triphosphonu~ieotid~ regenerating system identical 
to that used for the adenyiate cyclase assay. The 
reaction was initiated by the addition of mem- 
branes (30-50 pg protein), and allowed to proceed 
for 30 min at 22°C. Bound [3H]~giotensin was 
separated from free f3H]angiotensin as in [ 141. 
Non-specific binding was determined in the 
presence of 1 FM unlabeled angiotensin. It 
represented about lOolo of total binding at 5 nM 
~3H]an~otens~. 
3, RESULTS AND DISCUSSION 
The results from 13H]angiotensin binding ex- 
periments are summarized in fig. 1. Under control 
conditions (absence of added magnesium, NaCl 
and GTP) determination of dose-dependent bind- 
ing at equilibrium revealed an heterogeneity in the 
pop~iation of binding sites as indicated by a 
curvilinear Scatchard plot. Addition of magnesium 
(1 mM) increased the proportion of high affinity 
sites but did not completely suppress receptor 
heterogeneity. In the presence of NaCl, 100 mM, 
the dose-binding curve led to an almost linear Scat- 
chard plot. Apparem & and maximal binding 
capacity were respectively, 5 nM and 550 fmoi/mg 
protein. The mean correspondin values derived 
from a series of 8 experiments were 4.0 + 0.2 nM 
and 440 f 61 fmol/mg protein. Addition of GTP 
(1OOpM) slightly reduced the maximal binding 
capacity and increased the apparent & (fig. 1 right 
upper panel). The mean & in the presence of GTP 
was 11.7 + 0.3 nM. The GTP effect was dose- 
dependent with an apparent I&value of 50 nM. 
5 ’ -G~anyiimidodiphosphate (Gpp (NH)p) was as 
potent and as efficient as GTP. As illustrated in 
fig,l, left lower panel, the ~anylnucieotide- 
induced decrease in hormone-binding was depen- 
dent on the NaCl concentration in the incubation 
medium. The maximal NaCl effect was observed 
between 100 and 200 mM. The effect of MgZC 
reached a maximal value at 3 mM; higher concen- 
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Fig. 1. Effects of magnesium, sodium chloride and GTP 
on [3H]angiotensin-binding to bovine adrenal cortex 
membranes. Left upper panel: Scatchard plots of dose- 
dependent [‘Hlangiotensin-binding determined in the 
presence of NaCl, 100 mM (o), MgC12, 3 mM (0) and 
under control conditions (A). Data on the graph are 
means of 8 experiments. Right upper panel: Scatchard 
plots of dose-dependent [3H]angiotensin-binding 
determined in the presence of NaCI, 100 mM alone (0) 
and in the presence of NaCl plus GTP (lOO/cM). The 
calculated &-values and maximal binding capacities 
were, respectively, 4.9 and 10 nM and 610 and 
402 fmol/mg protein. Left lower panel: Specific 
[‘Hlangiotensin (4 nM)-binding was determined in the 
presence (0) or absence (0) of GTP (100 ,uM) and in the 
presence of the indicated amounts of MgClz. Insert: the 
percent inhibition due to GTP is plotted as a function of 
magnesium concentration. Right lower panel: Specific 
13H]angiotensin (4 mM)-binding was determined in the 
presence of GTP, 100 FM, and the indicated amounts of 
NaCl. Data are expressed as 5’0 of control values 
(absence of NaCI). 
trations were inhibitory. The relative inhibition of 
angiotensin binding by guanylnucleotides was 
slightly increased when increasing magnesium con- 
centration (fig. 1). The above described data on the 
guanylnucleotide and NaCl effect on angiotensin- 
binding confirm the data reported in [IS]. In addi- 
tion, they indicate that magnesium ions might also 
be a regulatory ligand of the receptor. The obser- 
vation (not shown) that the binding of an agonist 
to the angiotensin receptor is not affected by 
magnesium, reinforces this interpretation. Thus it 
appears that angiotensin receptors from bovine 
adrenal cortex are sensitive to the 3 putative effec- 
tors (Mg’+, guanylnucleotide and monovalent 
ions) involved in receptor-mediated inhibition of 
adenylate cyclase. 
Preliminary experiments on the adenylate 
cyclase from bovine adrenal cortex indicated that 
enzyme activity was sensitive to Mg2+, GTP and 
NaCl. GTP (100 PM) increased basal activity by 
about 50%. NaCl(lO0 mM) alone had a similar ef- 
fect. A combination of NaCl, 100 mM and GTP, 
100 ,uM led to a further increase in enzyme activity. 
As shown in fig.2, the NaCl component of the 
combined GTP plus NaCl stimulation was ap- 
parent at all magnesium concentrations tested bet- 
ween 0.1 to 10 mM. Magnesium ions increased in 
similar proportions activities determined in the 
presence of GTP and GTP plus NaCl. The effect 
of angiotensin II (1 mM) was tested in the presence 
and absence of NaCl and as a function of 
magnesium concentrations. The results obtained 
are shown in fig.3 and table 1. Both in the presence 
and absence of NaCl, angiotensin inhibited 
adenylate cyclase activity. The highest relative in- 
hibition observed was obtained at low magnesium 
concentrations 47 and 53% at 0.5 mM, MgZf and 
16 and 16% at 10 mM Mg2+ in the absence and 
presence of NaCI, respectively. In the absence of 
NaCI, ACTH induced a marked activation of 
adenylate cyclase. The relative activation was more 
[Magnesium] (log M) 
Fig.2. Effects of magnesium and sodium chloride on 
basal adenylate cyclase activity from bovine adrenal 
cortex membranes. Adenylate cyclase activity was 
determined in the presence of the indicated amounts of 
MgC12 with (0) or without (0) NaCl 100 mM. Values 
are means of 3 expt. 
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Fig.3. Effect of angiotensin on basal and ACTH- 
stimulated adenylate cyclase activity from bovine 
adrenal cortex membranes. The figure shows the results 
of a typical experiment. Determinations were performed 
in the presence (right panel) or absence (left panel) of 
NaCl 100 mM. Activities were determined under basal 
conditions (e), in the presence of 1 PM ACTH (A), 
1 pM angiotensin (0) and ACTH plus angiotensin (A). 
pronounced at low magnesium concentration 
(364% at 0.5 mM Mg2+ as compared to 100% at 
5 and 10 mM). Angiotensin inhibited ACTH- 
stimulated activity; however, the relative inhibition 
was less pronounced than observed in the absence 
Table I 
Inhibition by angiotensin of bovine adrenal cortex 
adenylate cyclase 
2+ 
ZM) 
Adenylate cyclase activity Inhibi- 
@mol. min-r . mg protein-‘) tion 
(%) 
Basal Reduction due to 
angiotensin 
0.1 0.52 f 0.10 0.18 f O.OY 35 
0.5 1.96 f 0.22 0.43 f 0.25b 22 
1.0 3.27 -I 0.17 0.71 f o.40b 22 
5.0 8.99 f 0.86 1.4 f O.gb 16 
10.0 13.17 f 1.17 2.3 k 2.2NS 17 
= p < 0.01; b p < 0.05; NS, p > 0.05 
The table summarizes the results of experiments imilar 
to that described in fig.3. Values are means f SD of 9 
determinations. The mean differences between activities 
determined in the presence and absence of angiotensin 
(1OOpM) were compared to zero using the Student’s t- 
test for paired values 
of ACTH. In the presence of NaCl, stimulation of 
adenylate cyclase by ACTH was markedly reduced 
at low magnesium concentration and almost com- 
pletely abolished at 10 mM magnesium. Inhibition 
by angiotensin at low magnesium concentration 
was still apparent. 
Angiotensin also inhibited adenylate cyclase ac- 
tivity from rat adrenal cortex (not shown). The in- 
hibition was also dependent on the magnesium 
concentration and had a magnitude comparable to 
that observed for bovine adrenal cortex adenylate 
cyclase . 
The angiotensin-induced inhibition of bovine 
adrenal cortex adenylate cyclase was dose- 
dependent (fig.4). The observed &-value of 2 nM 
is close to the Kd for angiotensin-binding (4-5 nM, 
see above). 
It seems reasonable to conclude that angiotensin 
can inhibit adenylate cyclase activity from rat and 
bovine adrenal cortex. The inhibition is revealed in 
the presence of GTP. The requirement for a 
monovalent ion is less apparent than reported in 
the case of rat liver [4,5] and rat renal cortex mem- 
branes [6]. We show that inhibition by angiotensin 
of adrenal cortex adenylate cyclase is dependent on 
the magnesium concentration in the incubation 
medium. It is increased at low magnesium concen- 
tration and markedly reduced at 10 mM 
magnesium. The conditions (presence of GTP and 
NaCl, reduction of the magnesium concentration) 
which affect angiotensin-induced adenylate cyclase 
inhibition are also the conditions in which agonist- 
-10 -8 -6 -4 
[Anglotensln] (log Ml 
Fig.4. Dose-dependent inhibition of bovine adrenal 
cortex adenylate cyclase by angiotensin. Adenylate 
cyclase activity was determined in the presence of the 
indicated amounts of angiotensin. The incubation 
medium contained NaCl, 100 mM and MgC12, 0.5 mM. 
100 
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specific changes in receptor affinity were 
demonstrated (not shown). This observation might 
indicate that, at least a large fraction of the 
detected angiotensin-binding sites are the receptors 
involved in adenylate cyclase inhibition. The com- 
parable dose-dependencies for hormone binding 
and adenylate cyclase inhibition is an additional 
argument favoring this conclusion. 
Our results, together with previously published 
data, are compatible with the hypothesis that the 
ability to inhibit adenylate cyclase might be a 
general property of angiotensin receptors. The 
physiological significance of this effect remains to 
be established. For hepatocytes and adrenal cells in 
which the same function (glycogenolysis and 
steroidogenesis) was found to be regulated both by 
cyclic AMP and calcium-dependent pathways, one 
might suggest hat adenylate cyclase inhibition by 
a calcium mobilizing agent such as angiotensin 
might contribute to a switch from one regulatory 
pathway to the other. 
ACKNOWLEDGEMENTS 
This work was supported by the Centre National 
de la Recherche Scientifique, the Institut National 
de la Recherche Scientifique et Technique, and the 
Fondation pour la Recherche Medicale. We thank 
J.L. Morgat for the preparation of [3H]angioten- 
sin and D. Vidal-Chicot for skillful technical 
assistance. 
REFERENCES 
111 
121 
131 
141 
151 
161 
171 
181 
191 
1101 
I111 
1121 
1131 
1141 
1151 
De Wulf, H., Keppens, S., Vandenheede, J.R., 
Haustraete, F., Proost, C. and Carton, H. (1980) 
in: Hormones and Cell Regulation (Dumont, J. and 
Nunez, J. eds) ~01.4, pp.47-71, Elsevier, Amster- 
dam, New York. 
Peach, M.J. (1977) Physiol. Rev. 57, 313-370. 
Fakunding, J.L. and Catt, K.J. (1980) 
Endocrinology 107, 1345-1353. 
Jard, S., Cantau, B. and Jakobs, K.H. (1981) J. 
Biol. Chem. 256, 2603-2606. 
Crane, J.K., Campanile, C.P. and Garrison, J.C. 
(1982) J. Biol. Chem. 257, 4959-4965. 
Woodcock, E.A. and Johnston, C.I. (1982) 
Endocrinology 111, 1687-1691. 
Rodbell, M. (1980) Nature 284, 17-22. 
Devnyck, M.A. and Meyer, P. (1978) Biochem. 
Pharmac. 27, l-5. 
Glossmann, H., Baukal, A. J. and Catt, K. J. (1974) 
J. Biol. Chem. 249, 825-834. 
Salomon, Y., Londos, C. and Rodbell, M. (1974) 
Anal. Biochem. 58, 541-548. 
Birnbaumer, L. and Yang, P.C. (1974) J. Biol. 
Chem. 249, 3170-3180. 
Lowry, O.H., Rosebrough, N.J., Far-r, A.L. and 
Randall, R.J. (1951) J. Biol. Chem. 193, 265-275. 
Morgat, J.L., Hung, L.T. and Fromageot, P. 
(1970) Biochim. Biophys. Acta 207, 374-376. 
Keppens, S., De Wulf, H., Clauser, P., Jard, S. 
and Morgat, J.L. (1982) Biochem. J. 208,809-817. 
Glossmann, H., Baukal, A. and Catt, K.J. (1974) 
J. Biol. Chem. 249, 664-666. 
101 
